Pseudomembranous Colitis a Special Case
As soon as pseudomembranous colitis is suspected, the implicated antibacterial should be withdrawn, symptomatic treatment of diarrhoea started and specific antibacterial therapy initiated. The diagnosis can be confirmed by the isolation of C. difficile or its toxins in stool.
Two antibacterials have been shown to be effective in the treatment of pseudomembranous colitis: oral or parenteral metronidazole (250mg 4 times daily for 7 to 10 days) and oral vancomycin (from 125mg 3 times daily to 500mg 4 times daily in severe cases). Vancomycin is well tolerated compared with metronidazole but its cost is higher.
severe life-threatening colitis
allergy to metronidazole
age <10 years.
Complications of pseudomembranous colitis may require endoscopic exsufflation or colectomy.
Pseudomembranous colitis presents a risk of relapse, which has been seen in 20% of patients. No therapeutic approach has been found to effectively reduce the rate of relapse. Nevertheless, it is recommended not to prescribe any antibacterial for 2 months after an episode of pseudomembranous colitis. Afterwards, if the patient requires an anti-bacterial, it has been proposed that either metronidazole or vancomycin should be used in combination with the antibacterial.
© 2001 Adis Data Information BV
Cite this: Drug-Induced Diarrhoea: A Far From Rare Adverse Event - Medscape - Jan 15, 2001.